| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/16/2009 | CN101530566A Drug for treating rheumatism and rheumatoid disease |
| 09/16/2009 | CN101530545A Quality standard for musk analgesic spray Chinese medicinal preparation and inspection method thereof |
| 09/16/2009 | CN101530542A Oral pharmaceutical preparation of chinaroot greenbrier total aglycon and preparation method and application thereof |
| 09/16/2009 | CN101530540A Drug for curing rheumatoid arthritis |
| 09/16/2009 | CN101530534A Oral pharmaceutical preparation of dioscorea panthaica total sapogenin and preparation method and application thereof |
| 09/16/2009 | CN101530533A Oral pharmaceutical preparation of dioscorea zingiberensis wright total sapogenin and preparation method and application thereof |
| 09/16/2009 | CN101530532A Oral pharmaceutical preparation of yam total sapogenin and preparation method and application thereof |
| 09/16/2009 | CN101530522A Chinese medicine preparation for treating wind-cold-dampness pains |
| 09/16/2009 | CN101530521A Powdered medicine with special effect for eliminating pain of heel |
| 09/16/2009 | CN101530512A Herb tea for curing rheumatism and rheumatoid diseases |
| 09/16/2009 | CN101530510A Chinese medicine used for treating shoulder neck pain and lumbocrural pain and preparation method thereof |
| 09/16/2009 | CN101530503A Chinese medicinal composition for treating rheumatism and preparation method thereof |
| 09/16/2009 | CN101530491A Method of preparing gardenia extract by applying membrane filtration technology |
| 09/16/2009 | CN101530484A Blood-activating bone-strengthening plaster |
| 09/16/2009 | CN101530474A Compound qinlan oral liquid |
| 09/16/2009 | CN101530470A Medicament for treating rheumatism and rheumatoid disease, and preparing method thereof |
| 09/16/2009 | CN101530465A Total salvianolic acid and Panax notoginsenosides and application of mixture thereof in treatment of septicemia |
| 09/16/2009 | CN101530448A External Chinese medicinal plaster for treating traumatic injury |
| 09/16/2009 | CN101530443A Asarum volatile oil prepared by system solvent method and use thereof |
| 09/16/2009 | CN101530442A Asarum volatile oil prepared by vacuum distillation method and use thereof |
| 09/16/2009 | CN101530440A Oral pharmaceutical preparation of aralia elata total sapogenin and preparation method and application thereof |
| 09/16/2009 | CN101530439A Method for preparing bupleurum extract by applying membrane filtration technology |
| 09/16/2009 | CN101530437A Method for extracting flavonoid compound from bracken |
| 09/16/2009 | CN101530436A Method of effectively extracting ganoderma triterpenoids and ganoderan from mythic fungus germ entity |
| 09/16/2009 | CN101530421A A Bianque stone paste and a preparation method thereof |
| 09/16/2009 | CN101530406A Compound enteric-coated preparation and preparation method thereof |
| 09/16/2009 | CN101530401A Compound transdermal patch used for curing acute and chronic inflammatory pain |
| 09/16/2009 | CN100540560C Compounds that interact with kinases |
| 09/16/2009 | CN100540028C Film coating agent fro treating wound, bone ache caused from wind dampness and preparing method |
| 09/15/2009 | US7590494 leukotriene A4 (LTA4) hydrolase; identifying enzyme inhibitors, as antiinflammatory agents |
| 09/15/2009 | US7589232 5-[(3-Cyclopentylpropanoyl)(4-dec-1-ynylbenzyl)amino]-2-hydroxybenzoic acid; inflammatory disorder, obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglycerimia |
| 09/15/2009 | US7589202 Substituted pyrazoles |
| 09/15/2009 | US7589200 5-Fluoro-4N-phenyl-4-pyrimidineamine compounds |
| 09/15/2009 | US7589125 2-acetoxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoic acid; methyl 2-hydroxy-4-(2,2,3,3,3-pentafluoropropoxy)benzoate; psoriasis and other immune diseases |
| 09/15/2009 | US7589112 Methylene urea derivatives |
| 09/15/2009 | US7589095 4-(3-hydroxy-1-propyl)-6-(3-trifluoromethylphenyl)-pyrimidine-2-carbonitrile; cysteine proteases (cathepsin K and S) inhibitor; antiinflammatory and analgesic agent; rheumatoid arthritis, multiple sclerosis, chronic and neuropathic pain |
| 09/15/2009 | US7589091 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 09/15/2009 | US7588761 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 09/15/2009 | US7588760 Binds to a denatured collagens but not to native triple helical forms of the collagen; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists |
| 09/15/2009 | CA2463583C Highly compressible ethylcellulose for tableting |
| 09/15/2009 | CA2419397C Novel use of a peptide class of compound for treating non neuropathic inflammatory pain |
| 09/15/2009 | CA2415752C Novel disaccharides with anti-arthritic action |
| 09/15/2009 | CA2415065C Oral compositions comprising host-response modulating agent |
| 09/15/2009 | CA2364665C Phenyl- and pyridinyl derivatives |
| 09/15/2009 | CA2342985C Hydroxamate-containing cysteine and serine protease inhibitors |
| 09/15/2009 | CA2218699C 1,3-propane diol derivatives as bioactive compounds |
| 09/15/2009 | CA2149925C Peptidic derivates of .alpha.-msh and their uses |
| 09/11/2009 | WO2009111607A1 Hydroxyalkanyl amides as modulators of chemokine receptor activity |
| 09/11/2009 | WO2009111603A2 Deitary supplement for eye health |
| 09/11/2009 | WO2009111547A1 7h-pyrrolo[2,3-h]quinazoline compounds, their use as mtor kinase and pi3 kinase inhibitors, and their synthesis |
| 09/11/2009 | WO2009110546A1 Composition containing aqueous extract of ashwaganda leaves as the active ingredient and method of producing the same |
| 09/11/2009 | WO2009110519A1 Novel 1-aminocarbonylpiperidine derivative |
| 09/11/2009 | WO2009109911A1 Methods of treating chronic pain |
| 09/11/2009 | WO2009109908A1 Methods of treating inflammatory pain |
| 09/11/2009 | WO2009109850A2 A method of treating or preventing pain |
| 09/11/2009 | WO2009109836A1 Oral galenic formulation including ketorolac and b-complex vitamins, in which vitamin b6 is in an outer layer separated from the rest of the active principles |
| 09/11/2009 | WO2009109618A2 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 09/11/2009 | WO2009109613A2 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 09/11/2009 | WO2009109501A2 Ocular pharmaceutical compositions |
| 09/11/2009 | WO2009109483A1 Leukotriene b4 inhibitors |
| 09/11/2009 | WO2009109401A1 Salts of memantine and cox-inhibitors and their crystalform in the treatment of pain |
| 09/11/2009 | WO2009109364A1 Substituted sulfonamide derivatives |
| 09/11/2009 | WO2009109356A1 Cytostatic compositions |
| 09/11/2009 | WO2009109334A1 (s)-(+)-2-[4-fluorbenzyloxy)benzylamino]propanamide for use in the treatment of mixed or combined pain |
| 09/11/2009 | WO2009088849A3 Treatment or prevention of inflammation by targeting cyclin d1 |
| 09/11/2009 | WO2009050198A3 Combination comprising purine derivatives and other compounds and the use thereof for the treatment of inflammatory and obstructive airway diseases |
| 09/11/2009 | WO2009007827A9 Novel diclofenac esters and uses thereof |
| 09/11/2009 | WO2008150308A3 Bcl-2 proteins for inhibiting cell death or inflammation in mammals |
| 09/11/2009 | CA2753844A1 Compositions and methods for mucositis and oncology therapies |
| 09/11/2009 | CA2717900A1 Oral galenic formulation including ketorolac and b-complex vitamins, in which vitamin b6 is in an outer layer separated from the rest of the active principles |
| 09/11/2009 | CA2717692A1 N-substituted benzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation |
| 09/11/2009 | CA2717604A1 Substituted sulfonamide derivatives |
| 09/11/2009 | CA2717202A1 Leukotriene b4 inhibitors |
| 09/11/2009 | CA2716799A1 Methods of treating inflammatory pain |
| 09/11/2009 | CA2716424A1 Methods of treating chronic pain |
| 09/11/2009 | CA2712703A1 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 09/11/2009 | CA2712403A1 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40 |
| 09/10/2009 | US20090228997 Extracellular novel RAGE binding protein ( EN-RAGE) and uses thereof |
| 09/10/2009 | US20090227683 Compositions for Providing an Analgesic Effect to the Skin |
| 09/10/2009 | US20090227662 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 09/10/2009 | US20090227654 Modulation of Neuroglia-Derived BDNF in the Treatment and Prevention of Pain |
| 09/10/2009 | US20090227645 Pharmaceutical compositions of valdecoxib |
| 09/10/2009 | US20090227625 Cxcr2 inhibitors |
| 09/10/2009 | US20090227620 Anti-inflammatory compounds |
| 09/10/2009 | US20090227609 Amidine derivatives of 2-heteroaryl-quinazolines and quinolines; potent analgesics and anti-inflammatory agents |
| 09/10/2009 | US20090227606 Methods for Preventing or Treating Acute and Chronic Pain |
| 09/10/2009 | US20090227603 Leukotriene b4 inhibitors |
| 09/10/2009 | US20090227601 Bradykinin 1 Receptor Antagonists |
| 09/10/2009 | US20090227596 Heteroaryl nitrile derivatives |
| 09/10/2009 | US20090227595 Glycine transporter-1 inhibitors |
| 09/10/2009 | US20090227585 Substituted n-heterocycle derivatives and methods of their use |
| 09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/10/2009 | US20090227544 Bone Targeted Therapeutics and Methods of Making and Using the Same |
| 09/10/2009 | US20090227523 Use of compatible solutes as substances having free radical scavenging properties |
| 09/10/2009 | US20090227505 Methods and uses for protein breakdown products |
| 09/10/2009 | US20090227499 Soluble gp130 molecule variants useful as a medicament |
| 09/10/2009 | US20090227487 Methods for the control of macrophage-associated inflammation |
| 09/10/2009 | US20090226987 Desaturase Genes, Enzymes Encoded Thereby, and Uses Thereof |
| 09/10/2009 | US20090226547 Dietary Supplement For Eye Health |
| 09/10/2009 | US20090226499 Biocompatible materials containing stable complexes of tsg-6 and hyaluronan and method of using same |